PEAK6 Group’s BIO-REFERENCE LABS INC-NEW- BRLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-1,100
Closed -$45K 6036
2015
Q2
$45K Sell
1,100
-122,500
-99% -$4.39M ﹤0.01% 4613
2015
Q1
$4.36M Buy
+123,600
New +$4.18M 0.03% 756
2014
Q4
Sell
-29,300
Closed -$822K 5619
2014
Q3
$822K Sell
29,300
-30,500
-51% -$929K 0.01% 2002
2014
Q2
$1.81M Sell
59,800
-413,200
-87% -$11.4M 0.02% 1131
2014
Q1
$13.1M Buy
473,000
+150,000
+46% +$3.93M 0.11% 184
2013
Q4
$8.25M Buy
323,000
+107,200
+50% +$3.3M 0.06% 417
2013
Q3
$3.23M Buy
215,800
+104,900
+95% +$2.92M 0.02% 1151
2013
Q2
$3.19K Buy
+110,900
New +$3.06M 0.01% 1110

Other funds holding BRLI

PEAK6 Group's BRLI Position: Q3 2015 in Review

PEAK6 Group sold out of BIO-REFERENCE LABS INC-NEW- (BRLI) in Q3 2015, closing a stake of 9,063 shares — an estimated $374K sold.

PEAK6 Group first reported a position in BRLI in Q2 2015 and held it in 1 quarter. The position peaked at $374K in Q2 2015. 1 fund tracked by Wall St. Rank holds BRLI as of Q3 2015.

  • PEAK6 Group reported no remaining BIO-REFERENCE LABS INC-NEW- position as of Q3 2015 after selling out during the quarter.
  • PEAK6 Group sold 9,063 BIO-REFERENCE LABS INC-NEW- shares in Q3 2015, an estimated $374K.
  • PEAK6 Group first reported a position in BIO-REFERENCE LABS INC-NEW- in Q2 2015 and held it in 1 quarter.
  • PEAK6 Group's BIO-REFERENCE LABS INC-NEW- position peaked at $374K in Q2 2015.
  • 1 fund tracked by Wall St. Rank held BIO-REFERENCE LABS INC-NEW- as of Q3 2015.

Based on PEAK6 Group's 13F filing for Q3 2015, filed 16 Nov 2015.